During the past decade, Chengdu Eighth People's Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chengdu Eighth People's Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Tian Xie" with 2 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Chinese PLA General Hospital" with 1 trials sponsored and "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chengdu Eighth People's Hospital" #1 collaborator was "LinkDoc Technology (Beijing) Co. Ltd." with 2 trials as a collaborator, "Chengdu Seventh People's Hospital" with 1 trials as a collaborator, "Chengdu Third People's Hospital" with 1 trials as a collaborator, "Dazhu County People's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Chengdu Eighth People's Hospital" are "Acute Ischemic Stroke" (2 trials), "Acute Ischaemic Stroke" (1 trials), "Adenocarcinoma" (1 trials), "Alzheimer Disease" (1 trials) and "CKD (Chronic Kidney Disease) Stage 5D" (1 trials). Many other conditions were trialed in "Chengdu Eighth People's Hospital" in a lesser frequency.

Most popular intervention types in "Chengdu Eighth People's Hospital" are "Drug" (9 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alteplase" (2 trials), "Aspirin 100 mg Oral Tablet" (1 trials), "Atorvastatin Calcium tablets 20mg" (1 trials), "Atorvastatin Calcium tablets 80mg" (1 trials) and "BI 685509" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chengdu Eighth People's Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Chengdu Eighth People's Hospital". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Chengdu Eighth People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chengdu Eighth People's Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".